Iovance Biotherapeutics, Inc. Stock News

It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.

It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.

However, $306 million of the federal money has been set aside for the National Cancer Institute to expand antibody testing capacity and fund research projects, according to a public presentation last

In the early days of the pandemic, patients and doctors were uncertain about how they would proceed with research — but no one ever doubted that they would.

In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research Report),

Hat in hand: U.S. scientists scramble to support their COVID immunity research

The

The NCI and FDA should take to ensure that our science is sound and that our public health decisions are based on strong foundations.

This “cytokine storm” was once an arcane phenomenon familiar mainly to rheumatologists who study when and how the immune system’s safeguards fail.

Aura Biosciences, a clinical-stage biopharmaceutical company developing a novel class of tumor targeted therapies for initial application in primary t

Stand Up To Cancer, a nonprofit that supports funding for cancer research, launched a new initiative to expand minority representation in clinical trials. The nonprofit will seek proposals later this

Genes determine more than how we look, but that’s not where the story ends. Happiness is a skill we can learn.

Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re

Coronavirus treatment of severe cases is still problematic, but doctors may have found an effective drug that can reduce the inflammatory response in COVID-19 patients who develop respiratory compl…